Contraindications to Stem Cell Treatment

 

Stem cell-based treatment is a medical procedure that requires careful evaluation of each patient’s individual health status. Although stem cell therapies may offer potential therapeutic benefits for certain conditions, they are not suitable for every patient.

Before treatment, our medical team reviews the patient’s medical history, current diagnosis, medications, previous treatments, laboratory results, and general health. This assessment helps determine whether stem cell treatment can be performed safely and whether any medical conditions require additional investigation or stabilization before treatment.

When Stem Cell Treatment May Not Be Recommended

Contraindications may vary depending on the patient’s condition, the type and source of stem cells, the planned route of administration, and the specific treatment protocol.

Stem cell treatment may be postponed or contraindicated in patients with certain medical conditions, including:

• Certain genetic or hereditary disorders — for example, neurofibromatosis, tuberous sclerosis, cystic fibrosis, or muscular dystrophy. Such conditions may require additional genetic and medical evaluation before treatment can be considered.
• Metabolic disorders or mitochondrial dysfunction — significant metabolic abnormalities or mitochondrial dysfunction may affect the patient’s overall condition and require careful assessment before treatment.
• Active infections — for example, hepatitis B (HBV), hepatitis C (HCV), or HIV infection. Active or uncontrolled infections may increase the risks associated with a medical procedure and may require treatment or stabilization before stem cell therapy is considered.
• Active malignant disease or certain types of cancer — the presence of an active malignancy may represent a significant contraindication depending on the patient’s diagnosis, current treatment, and the proposed cell-based therapy.
• Major organ damage or severe systemic disease — for example, significant damage affecting the heart, lungs, liver, kidneys, or other major organs may make treatment unsafe or require additional medical evaluation.
• Severe disorders of the blood or immune system — conditions that significantly affect immune function, blood production, or the body’s ability to respond safely to treatment may require further assessment before therapy.
• Significant abnormalities in laboratory tests — for example, clinically important abnormalities affecting blood counts, blood clotting, liver or kidney function may need to be investigated or corrected before treatment.
• Certain neurological conditions — for example, epilepsy may require individual assessment of disease severity, control, current medication, and the proposed treatment protocol.
• Physical features suggestive of a genetic syndrome — suggestive physical dysmorphology may indicate an underlying genetic disorder. In such cases, additional diagnostic evaluation may be recommended before treatment.
• Pregnancy or breastfeeding — treatment may be postponed when the safety of the proposed cell-based intervention has not been established during pregnancy or breastfeeding.
• Known hypersensitivity or contraindication to medications or substances — for example, a documented severe allergic reaction to a medication required as part of the treatment protocol may prevent or postpone treatment.
• Other serious or uncontrolled medical conditions — any condition associated with a significant risk of life-threatening complications, including severe uncontrolled systemic disease, may require stabilization before treatment can be considered.

These examples are not exhaustive. The presence of a particular diagnosis does not necessarily mean that stem cell treatment is permanently excluded. The decision depends on the patient’s individual medical condition, the severity and control of the disease, and the specific treatment protocol.

Individual Medical Assessment Is Essential

There is no single list of contraindications that applies equally to every stem cell-based intervention. The safety profile of a treatment depends on several factors, including the characteristics of the cells, how they are prepared and administered, the patient’s underlying condition, and other medical treatments the patient may be receiving.

For this reason, eligibility for treatment is determined on an individual basis following a medical evaluation.

If a potentially reversible medical problem is identified, treatment may be postponed until the patient’s condition has been appropriately investigated or stabilized. In some cases, additional laboratory tests, diagnostic examinations, genetic testing, or consultations with relevant specialists may be required before a final decision can be made.

Safety Before Treatment

Patient safety is the primary consideration when evaluating eligibility for stem cell treatment. The medical team should have sufficient information about the patient’s current health status to assess the potential risks and benefits of the proposed procedure.

Patients should provide complete and accurate information about:

• current and previous medical conditions;
• medications and supplements;
• allergies and previous adverse reactions;
• previous surgeries or medical procedures;
• recent infections or fever;
• previous cancer or oncological treatment;
• pregnancy or breastfeeding, where applicable;
• genetic diagnoses or suspected hereditary conditions;
• and any other relevant changes in health.

Providing complete medical information allows the treating physicians to make a more informed assessment and reduce avoidable risks.

What Happens If Treatment Is Not Immediately Possible?

A contraindication does not always mean that stem cell treatment can never be performed. In some situations, treatment may simply need to be delayed while an underlying medical problem is investigated or treated.

After reviewing the available medical information, the physician may recommend additional examinations, treatment of an underlying condition, or consultation with another specialist. Once the patient’s medical status has been clarified, eligibility can be reassessed where appropriate.

However, if the potential risks remain greater than the expected benefits, the medical team may recommend against proceeding with treatment.

Your Safety Comes First

Stem cell treatment should never be considered a one-size-fits-all procedure. A responsible medical assessment should take into account the individual patient’s diagnosis, general health, potential risks, available alternatives, and the specific characteristics of the proposed cell-based intervention.

If you are considering stem cell treatment at Mardaleishvili Medical Center, our specialists can review your medical records and determine whether you may be an appropriate candidate for treatment.

A final decision regarding eligibility and contraindications can only be made by the treating physician after an individual medical assessment.